• 1  Virchow R. Zur Cellulose‐Frage. Virchows Archiv Pathol Anat Physiol Klin Med 1854;8:41626. Cross Ref link
  • 2  Breathnach SM. The cutaneous amyloidoses. Pathogenesis and therapy. Arch Dermatol 1985;121(4):4705. Cross Ref link Pubmed link
  • 3  Breathnach SM. Amyloid and amyloidosis. J Am Acad Dermatol 1988;18(1 Pt 1): 116. Cross Ref link Pubmed link
  • 4  Glenner GG. Amyloid deposits and amyloidosis. The beta‐fibrilloses (first of two parts). N Engl J Med 1980;302(23):128392. Cross Ref link Pubmed link
  • 5  Ollague W, Ollague J, Ferretti H. Epidemiology of primary cutaneous amyloidoses in South America. Clin Dermatol 1990;8(2):259. Cross Ref link Pubmed link
  • 6  Tan T. Epidemiology of primary cutaneous amyloidoses in southeast Asia. Clin Dermatol 1990;8(2):204. Cross Ref link Pubmed link
  • 7  Lin CS, Wong CK. Electron microscopy of primary and secondary cutaneous amyloidoses and systemic amyloidosis. Clin Dermatol 1990;8(2):3645. Cross Ref link Pubmed link
  • 8  Shapiro L, Kurban AK, Azar HA. Lichen amyloidosus. A histochemical and electron microscopic study. Arch Pathol 1970;90(6):499508. Pubmed link
  • 9  Kumakiri M, Hashimoto K. Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamentous degeneration. J Invest Dermatol 1979;73(2):15062. Cross Ref link Pubmed link
  • 10  Runne U, Orfanos CE. Amyloid production by dermal fibroblasts. Electron microscopic studies on the origin of amyloid in various dermatoses and skin tumours. Br J Dermatol 1977;97(2):15566. Cross Ref link Pubmed link
  • 11  Breathnach SM, Hintner H. Amyloid P‐component and the skin. Clin Dermatol 1990;8(2):4654. Cross Ref link Pubmed link
  • 12  Meyer‐Luehmann M, Coomaraswamy J, Bolmont T, et al. Exogenous induction of cerebral beta‐amyloidogenesis is governed by agent and host. Science 2006;313(5794):17814. Cross Ref link Pubmed link
  • 13  Esposito G, Michelutti R, Verdone G, et al.. Removal of the N‐terminal hexapeptide from human beta2‐microglobulin facilitates protein aggregation and fibril formation. Protein Sci 2000;9(5):83145. Cross Ref link Pubmed link
  • 14  Chen CD, Huff ME, Matteson J, et al. Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilization. EMBO J 2001;20(22):627787. Cross Ref link Pubmed link
  • 15  Bellotti V, Chiti F. Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. Curr Opin Struct Biol 2008;18(6):7719. Cross Ref link Pubmed link
  • 16  Relini A, De Stefano S, Torrassa S, et al. Heparin. strongly enhances the formation of beta2‐microglobulin amyloid fibrils in the presence of type I collagen. J Biol Chem 2008;283(8):491220. Cross Ref link Pubmed link
  • 17  Elimova E, Kisilevsky R, Ancsin JB. Heparan sulfate promotes the aggregation of HDL‐associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch. FASEB J 2009;23(10):343648. Cross Ref link Pubmed link
  • 18  Lim KH, Kim YK, Chang YT. Investigations of the molecular mechanism of metal‐induced Abeta (1‐40) amyloidogenesis. Biochemistry 2007;46(47):1352332. Cross Ref link Pubmed link
  • 19  Ellis RJ, Minton AP. Protein aggregation in crowded environments. Biol Chem 2006;387(5):48597. Cross Ref link Pubmed link
  • 20  Van den Berg B, Ellis RJ, Dobson CM. Effects of macromolecular crowding on protein folding and aggregation. EMBO J 1999;18(24):692733. Cross Ref link Pubmed link
  • 21  Frousios KK, Iconomidou VA, Karletidi CM, Hamodrakas SJ. Amyloidogenic determinants are usually not buried. BMC Struct Biol 2009;9:44. Cross Ref link Pubmed link
  • 22  Gazit E. Mechanisms of amyloid fibril self‐assembly and inhibition. Model short peptides as a key research tool. FEBS J 2005;272(23):59718. Cross Ref link Pubmed link
  • 23  Hamodrakas SJ, Liappa C, Iconomidou VA. Consensus prediction of amyloidogenic determinants in amyloid fibril‐forming proteins. Int J Biol Macromol 2007;41(3):295300. Cross Ref link Pubmed link
  • 24  Lopez de la Paz M, Serrano L. Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci USA 2004;101(1):8792. Cross Ref link Pubmed link
  • 25  Nerelius C, Fitzen M, Johansson J. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation. Biochem Biophys Res Commun 2010;396(1):26. Cross Ref link Pubmed link
  • 26  Zhang Z, Chen H, Lai L. Identification of amyloid fibril‐forming segments based on structure and residue‐based statistical potential. Bioinformatics 2007;23(17):221825. Cross Ref link Pubmed link
  • 27  McGlinchey RP, Shewmaker F, McPhie P, Monterroso B, Thurber K, Wickner RB. The repeat domain of the melanosome fibril protein Pmel17 forms the amyloid core promoting melanin synthesis. Proc Natl Acad Sci USA 2009;106(33):137316. Cross Ref link Pubmed link
  • 28  Watt B, van Niel G, Fowler DM, et al. N‐terminal domains elicit formation of functional Pmel17 amyloid fibrils. J Biol Chem 2009;284(51):3554355. Cross Ref link Pubmed link
  • 29  Schreml S, Kaiser E, Landthaler M, Szeimies RM, Babilas P. Amyloid in skin and brain: what's the link? Exp Dermatol 2010;19(11):9537. Cross Ref link Pubmed link
  • 30  Eisenberg D, Nelson R, Sawaya MR, et al. The structural biology of protein aggregation diseases: fundamental questions and some answers. Acc Chem Res 2006;39(9):56875. Cross Ref link Pubmed link
  • 31  Guo Z, Eisenberg D. The structure of a fibril‐forming sequence, NNQQNY, in the context of a globular fold. Protein Sci 2008;17(9):161723. Cross Ref link Pubmed link
  • 32  Nelson R, Sawaya MR, Balbirnie M, et al. Structure of the cross‐beta spine of amyloid‐like fibrils. Nature 2005;435(7043):7738. Cross Ref link Pubmed link
  • 33  Badtke MP, Hammer ND, Chapman MR. Functional amyloids signal their arrival. Sci Signal 2009;2(80):pe43. Cross Ref link Pubmed link
  • 34  Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid – from bacteria to humans. Trends Biochem Sci 2007;32(5):21724. Cross Ref link Pubmed link
  • 35  Turoverov KK, Kuznetsova IM, Uversky VN. The protein kingdom extended: ordered and intrinsically disordered proteins, their folding, supramolecular complex formation, and aggregation. Prog Biophys Mol Biol 2010;102(2–3):7384. Cross Ref link Pubmed link
  • 36  Gebbink MF, Claessen D, Bouma B, Dijkhuizen L, Wosten HA. Amyloids – a functional coat for microorganisms. Nat Rev Microbiol 2005;3(4):33341. Cross Ref link Pubmed link
  • 37  Babilas P, Travnik R, Werner A, Landthaler M, Szeimies RM. Split‐face‐study using two different light sources for topical PDT of actinic keratoses:non‐inferiority of the LED system. J Dtsch Dermatol Ges 2008;6(1):2532. Cross Ref link Pubmed link
  • 38  Maurer‐Stroh S, Debulpaep M, Kuemmerer N, et al. Exploring the sequence determinants of amyloid structure using position‐specific scoring matrices. Nat Methods 2010;7(3):73742. Cross Ref link Pubmed link
  • 39  Wang X, Chapman MR. Sequence determinants of bacterial amyloid formation. J Mol Biol 2008;380(3):57080. Cross Ref link Pubmed link
  • 40  Wang X, Zhou Y, Ren JJ, Hammer ND, Chapman MR. Gatekeeper residues in the major curlin subunit modulate bacterial amyloid fiber biogenesis. Proc Natl Acad Sci USA 2010;107(1):1638. Cross Ref link Pubmed link
  • 41  Epstein EA, Chapman MR. Polymerizing the fibre between bacteria and host cells: the biogenesis of functional amyloid fibres. Cell Microbiol 2008;10(7):141320. Cross Ref link Pubmed link
  • 42  Wang X, Hammer ND, Chapman MR. The molecular basis of functional bacterial amyloid polymerization and nucleation. J Biol Chem 2008;283(31):215309. Cross Ref link Pubmed link
  • 43  Wang X, Smith DR, Jones JW, Chapman MR. In vitro polymerization of a functional Escherichia coli amyloid protein. J Biol Chem 2007;282(6):371319. Cross Ref link Pubmed link
  • 44  Ramsook CB, Tan C, Garcia MC, et al. Yeast cell adhesion molecules have functional amyloid‐forming sequences. Eukaryot Cell 2010;9(3):393404. Cross Ref link Pubmed link
  • 45  Iconomidou VA, Hamodrakas SJ. Natural protective amyloids. Curr Protein Pept Sci 2008;9(3):291309. Cross Ref link Pubmed link
  • 46  Maji SK, Perrin MH, Sawaya MR, et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 2009;325(5938):32832. Cross Ref link Pubmed link
  • 47  Schreml S, Szeimies RM, Vogt T, Landthaler M, Schroeder J, Babilas P. Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement. Eur J Dermatol 2010;20(2):15260. Pubmed link
  • 48  Li WM. Histopathology of primary cutaneous amyloidoses and systemic amyloidosis. Clin Dermatol 1990;8(2):305. Cross Ref link Pubmed link
  • 49  Puchtler H, Sweat F. Congo red as a stain for fluorescence microscopy of amyloid. J Histochem Cytochem 1965;13(8):6934. Cross Ref link Pubmed link
  • 50  Glenner GG. The bases of the staining of amyloid fibers: their physico‐chemical nature and the mechanism of their dye‐substrate interaction. Prog Histochem Cytochem 1981;13(3):137. Cross Ref link Pubmed link
  • 51  Hobbs JR, Morgan AD. Fluorescence microscopy with thioflavine‐t in the diagnosis of amyloid. J Pathol Bacteriol 1963;86:43742. Cross Ref link Pubmed link
  • 52  Katsikas GA, Maragou M, Rontogianni D, Gouma P, Koutsouvelis I, Kappou‐Rigatou I. Secondary cutaneous nodular AA amyloidosis in a patient with primary Sjogren syndrome and celiac disease. J Clin Rheumatol 2008;14(1):279. Cross Ref link Pubmed link
  • 53  Love WE, Miedler JD, Smith MK, Mostow EN, Cooper KD, Gilliam AC. The spectrum of primary cutaneous nodular amyloidosis: two illustrative cases. J Am Acad Dermatol 2008;58(Suppl. 2):S335. Cross Ref link Pubmed link
  • 54  Chang YT, Liu HN, Wang WJ, Lee DD, Tsai SF. A study of cytokeratin profiles in localized cutaneous amyloids. Arch Dermatol Res 2004;296(2):838. Cross Ref link Pubmed link
  • 55  Arbustini E, Verga L, Concardi M, Palladini G, Obici L, Merlini G. Electron and immuno‐electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis. Amyloid 2002;9(2):10814. Pubmed link
  • 56  Van Gameren I, Hazenberg BP, Bijzet J, van Rijswijk MH. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum 2006;54(6):201521. Cross Ref link Pubmed link
  • 57  Westermark P, Davey E, Lindbom K, Enqvist S. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. Acta Histochem 2006;108(3):20913. Cross Ref link Pubmed link
  • 58  Newton JA, Jagjivan A, Bhogal B, McKee PH, McGibbon DH. Familial primary cutaneous amyloidosis. Br J Dermatol 1985;112(2):2018. Cross Ref link Pubmed link
  • 59  Vasily DB, Bhatia SG, Uhlin SR. Familial primary cutaneous amyloidosis. Clinical, genetic, and immunofluorescent studies. Arch Dermatol 1978;114(8):11736. Cross Ref link Pubmed link
  • 60  De Argila D, Ortiz‐Romero PL, Ortiz‐Frutos J, Rodriguez‐Peralto JL, Iglesias L. Cutaneous macular amyloidosis associated with multiple endocrine neoplasia 2A. Clin Exp Dermatol 1996;21(4):31314. Cross Ref link Pubmed link
  • 61  Gagel RF, Levy ML, Donovan DT, Alford BR, Wheeler T, Tschen JA. Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis. Ann Intern Med 1989;111(10):8026. Cross Ref link Pubmed link
  • 62  Verga U, Fugazzola L, Cambiaghi S, et al. Frequent association between MEN 2A and cutaneous lichen amyloidosis. Clin Endocrinol (Oxf) 2003;59(2):15661. Cross Ref link Pubmed link
  • 63  Tafarel JR, Lemos LB, Oliveira PM, Lanzoni VP, Ferraz ML. Cutaneous amyloidosis associated with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2007;19(7):6035. Cross Ref link Pubmed link
  • 64  Summers EM, Kendrick CG. Primary localized cutaneous nodular amyloidosis and CREST syndrome: a case report and review of the literature. Cutis 2008;82(1):559. Pubmed link
  • 65  Black MM. Lichen amyloidosus. An unusual clinical variant associated with the Koebner phenomenon. Acta Derm Venereol 1972;52(1):514. Pubmed link
  • 66  Kalajian AH, Waldman M, Knable AL. Nodular primary localized cutaneous amyloidosis after trauma: a case report and discussion of the rate of progression to systemic amyloidosis. J Am Acad Dermatol 2007;57(Suppl. 2):S269. Cross Ref link Pubmed link
  • 67  Borrowman TA, Lutz ME, Walsh JS. Cutaneous nodular amyloidosis masquerading as a foot callus. J Am Acad Dermatol 2003;49(2):30710. Cross Ref link Pubmed link
  • 68  Meijer JM, Schonland SO, Palladini G, et al. Sjogren's syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum 2008;58(7):19929. Cross Ref link Pubmed link
  • 69  Moon AO, Calamia KT, Walsh JS. Nodular amyloidosis: review and long‐term follow‐up of 16 cases. Arch Dermatol 2003;139(9):11579. Cross Ref link Pubmed link
  • 70  Grattan CE, Burton JL, Dahl MG. Two cases of nodular cutaneous amyloid with positive organ‐specific antibodies, treated by shave excision. Clin Exp Dermatol 1988;13(3):1879. Cross Ref link Pubmed link
  • 71  Brownstein MH, Helwig EB. Secondary systemic amyloidosis: analysis of underlying disorders. South Med J 1971;64(4):4916. Cross Ref link Pubmed link
  • 72  Hashimoto K, Brownstein MH. Localized amyloidosis in basal cell epitheliomas. Acta Derm Venereol 1973;53(5):3319. Pubmed link
  • 73  Hashimoto K, Kumakiri M. Colloid‐amyloid bodies in PUVA‐treated human psoriatic patients. J Invest Dermatol 1979;72(2):7080. Cross Ref link Pubmed link
  • 74  MacDonald DM, Black MM. Secondary localized cutaneous amyloidosis in melanocytic naevi. Br J Dermatol 1980;103(5):5536. Cross Ref link Pubmed link
  • 75  Powell AM, Albert S, Bhogal B, Black MM. Discoid lupus erythematosus with secondary amyloidosis. Br J Dermatol 2005;153(4):7469. Cross Ref link Pubmed link
  • 76  Ramirez‐Santos A, Suarez‐Amor O, Perez‐Perez L, Loureiro M, Peteiro C, Toribio J. [Localized cutaneous amyloidosis secondary to porokeratosis: a retrospective histopathologic study of 30 patients.] Acta Dermosifiliogr 2008;99(8):63943. Cross Ref link
  • 77  Furumoto H, Hashimoto Y, Muto M, Shimizu T, Nakamura K. Apolipoprotein E4 is associated with primary localized cutaneous amyloidosis. J Invest Dermatol 2002;119(2):5323. Cross Ref link Pubmed link
  • 78  Furumoto H, Shimizu T, Asagami C, et al. Apolipoprotein E is present in primary localized cutaneous amyloidosis. J Invest Dermatol 1998;111(3):41721. Cross Ref link Pubmed link
  • 79  Hashimoto K, Ito K, Taniguchi Y, Yang F, Youngberg G. Keratin in cutaneous amyloidoses. Clin Dermatol 1990;8(2):5565. Cross Ref link Pubmed link
  • 80  Kobayashi H, Hashimoto K. Amyloidogenesis in organ‐limited cutaneous amyloidosis: an antigenic identity between epidermal keratin and skin amyloid. J Invest Dermatol 1983;80(1):6672. Cross Ref link Pubmed link
  • 81  Fesus L, Szondy Z. Transglutaminase 2 in the balance of cell death and survival. FEBS Lett 2005;579(15):3297302. Cross Ref link Pubmed link
  • 82  Namazi MR. A possible pivotal role for transglutaminase 2 in the pathophysiology of cutaneous amyloidosis. Indian J Dermatol Venereol Leprol 2008;74(5):5212. Cross Ref link Pubmed link
  • 83  Malak JA, Smith EW. Secondary localized cutaneous amyloidosis. Arch Dermatol 1962;86:46577. Cross Ref link Pubmed link
  • 84  Abels C, Karrer S, Landthaler M, Szeimies RM. [Truss‐induced macular amyloidosis.] Hautarzt 2001;52(10 Pt 2):9703. Cross Ref link Pubmed link
  • 85  Vestey JP, Tidman MJ, McLaren KM. Primary nodular cutaneous amyloidosis – long‐term follow‐up and treatment. Clin Exp Dermatol 1994;19(2):15962. Cross Ref link Pubmed link
  • 86  Santos‐Juanes J, Galache C, Curto JR, Astudillo A, Sanchez del Rio J. Nodular primary localized cutaneous amyloidosis. J Eur Acad Dermatol Venereol 2004;18(2):2246. Cross Ref link Pubmed link
  • 87  Steciuk A, Dompmartin A, Troussard X, et al. Cutaneous amyloidosis and possible association with systemic amyloidosis. Int J Dermatol 2002;41(3):12732; discussion 33–4. Cross Ref link Pubmed link
  • 88  Lee DD, Lin MW, Chen IC, et al. Genome‐wide scan identifies a susceptibility locus for familial primary cutaneous amyloidosis on chromosome 5p13.1‐q11.2. Br J Dermatol 2006;155(6):12018. Cross Ref link Pubmed link
  • 89  Arita K, South AP, Hans‐Filho G, et al. Oncostatin M receptor‐beta mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet 2008;82(1):7380. Cross Ref link Pubmed link
  • 90  Lin MW, Lee DD, Lin CH, et al. Suggestive linkage of familial primary cutaneous amyloidosis to a locus on chromosome 1q23. Br J Dermatol 2005;152(1):2936. Cross Ref link Pubmed link
  • 91  Lin MW, Lee DD, Liu TT, et al. Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis. Eur J Hum Genet 2010;18(1):2632. Cross Ref link Pubmed link
  • 92  Babilas P, Fiebig BS, Aslanidis C, et al. Identification of an oncostatin M receptor mutation associated with familial. primary cutaneous amyloidosis. Br J Dermatol 2009;161(4):9447. Cross Ref link Pubmed link
  • 93  Tanaka A, Lai‐Cheong JE, van den Akker PC, et al. The molecular skin pathology of familial primary localized cutaneous amyloidosis. Exp Dermatol 2010;19(5):41623. Cross Ref link Pubmed link
  • 94  Wang WH, Li LF, Huang ES, et al. A new c.1845A→T of oncostatin M receptor‐beta mutation and slightly enhanced oncostatin M receptor‐beta expression in a Chinese family with primary localized cutaneous amyloidosis. Eur J Dermatol 2012;22(1):2933. Pubmed link
  • 95  Schreml S, Weber BH, Schroder J, et al. Familial primary localized cutaneous amyloidosis with an oncostatin M receptor‐beta mutation, Pro694Leu. Clin Exp Dermatol 2013;38:9325. Cross Ref link Pubmed link
  • 96  Brownstein MH, Helwig EB. The cutaneous amyloidoses. I. Localized forms. Arch Dermatol 1970;102(1):819. Cross Ref link Pubmed link
  • 97  Sidwell RU, Francis N, Roberts NM, Staughton RC. Allotropic cutaneous amyloidosis: coincidence or progression? Clin Exp Dermatol 2002;27(6):5268. Cross Ref link Pubmed link
  • 98  Ogino A, Tanaka S. Poikiloderma‐like cutaneous amyloidosis. Report of a case and review of the literature. Dermatologica 1977;155(5):3019. Cross Ref link Pubmed link
  • 99  Pardo Arranz L, Escalonilla Garcia‐Patos P, Roman Curto C, Blanco Barrios S, Fernandez Lopez E, de Unamuno Perez P. Familial poikylodermic cutaneous amyloidosis. Eur J Dermatol 2008;18(3):28991. Pubmed link
  • 100  Qiao J, Fang H, Yao H. Amyloidosis cutis dyschromica. Orphanet J Rare Dis 2012;7:95. Cross Ref link Pubmed link
  • 101  Fujita Y, Tsuji‐Abe Y, Sato‐Matsumura KC, Akiyama M, Shimizu H. Nail dystrophy and blisters as sole manifestations in myeloma‐associated amyloidosis. J Am Acad Dermatol 2006;54(4):7124. Cross Ref link Pubmed link
  • 102  Ruzicka T, Schmoeckel C, Ring J, Linke RP, Braun‐Falco O. Bullous amyloidosis. Br J Dermatol 1985;113(1):8595. Cross Ref link Pubmed link
  • 103  Stoopler ET, Alawi F, Laudenbach JM, Sollecito TP. Bullous amyloidosis of the oral cavity: a rare clinical presentation and review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(6):73440. Cross Ref link Pubmed link
  • 104  Wang XD, Shen H, Liu ZH. Diffuse haemorrhagic bullous amyloidosis with multiple myeloma. Clin Exp Dermatol 2008;33(1):946. Cross Ref link Pubmed link
  • 105  Woollons A, Black MM. Nodular localized primary cutaneous amyloidosis: a long‐term follow‐up study. Br J Dermatol 2001;145(1):1059. Cross Ref link Pubmed link
  • 106  Northcutt AD, Vanover MJ. Nodular cutaneous amyloidosis involving the vulva. Case report and literature review. Arch Dermatol 1985;121(4):51821. Cross Ref link Pubmed link
  • 107  Grunewald K, Sepp N, Weyrer K, et al. Gene rearrangement studies in the diagnosis of primary systemic and nodular primary localized cutaneous amyloidosis. J Invest Dermatol 1991;97(4):6936. Cross Ref link Pubmed link
  • 108  Kakani RS, Goldstein AE, Meisher I, Hoffman C. Nodular amyloidosis: case report. and literature review. J Cutan Med Surg 2001;5(2):1014. Cross Ref link Pubmed link
  • 109  Rubinow A, Cohen AS. Skin involvement in generalized amyloidosis. A study of clinically involved and uninvolved skin in 50 patients with primary and secondary amyloidosis. Ann Intern Med 1978;88(6):7815. Cross Ref link Pubmed link
  • 110  Kos CA, Ward JE, Malek K, et al. Association of acquired von Willebrand syndrome with AL amyloidosis. Am J Hematol 2007;82(5):3637. Cross Ref link Pubmed link
  • 111  Carvalho LO, Calabrese Kda S, da Costa SC, et al. Leishmania (Leishmania) amazonensis: experimental cutaneous leishmaniasis associated with systemic amyloidosis in mice. Exp Parasitol 2008;120(1):1235. Cross Ref link Pubmed link
  • 112  Jahn TR, Tennent GA, Radford SE. A common beta‐sheet architecture underlies in vitro and in vivo beta2‐microglobulin amyloid fibrils. J Biol Chem 2008;283(25):1727986. Cross Ref link Pubmed link
  • 113  Eder L, Bitterman H. Image in clinical medicine. Amyloid purpura. N Engl J Med 2007;356(23):2406. Cross Ref link Pubmed link
  • 114  Landa G, Aloni E, Milshtein A, Marcovich A, Mozes M, Pollack A. Eyelid bleeding and atypical amyloidosis. Am J Ophthalmol 2004;138(3):4956. Cross Ref link Pubmed link
  • 115  Schreml S, Schroeder J, Siegmund H, et al. Plasmocytoma‐induced intertriginous amyloid purpura. Ann Dermatol 2013;25(3):3912. Cross Ref link Pubmed link
  • 116  Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337(13):898909. Cross Ref link Pubmed link
  • 117  Harkany T, Garzuly F, Csanaky G, et al. Cutaneous lymphatic amyloid deposits in “Hungarian‐type” familial transthyretin amyloidosis:. a case report. Br J Dermatol 2002;146(4):6749. Cross Ref link Pubmed link
  • 118  Pepys MB. A molecular correlate of clinicopathology in transthyretin amyloidosis. J Pathol 2009;217(1):13. Cross Ref link Pubmed link
  • 119  Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol 2008;216(2):25361. Cross Ref link Pubmed link
  • 120  Mochizuki H, Kamakura K, Masaki T, et al. Nodular cutaneous amyloidosis and carpal tunnel syndrome due to the amyloidogenic transthyretin His 114 variant. Amyloid 2001;8(2):10510. Cross Ref link Pubmed link
  • 121  Kiuru‐Enari S, Keski‐Oja J, Haltia M. Cutis laxa in hereditary gelsolin amyloidosis. Br J Dermatol 2005;152(2):2507. Cross Ref link Pubmed link
  • 122  Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1969;1(4):31424. Pubmed link
  • 123  De la Chapelle A, Tolvanen R, Boysen G, et al. Gelsolin‐derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet 1992;2(2):15760. Cross Ref link Pubmed link
  • 124  Maury CP, Liljestrom M, Boysen G, Tornroth T, de la Chapelle A, Nurmiaho‐Lassila EL. Danish type gelsolin related amyloidosis: 654G‐T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G‐A mutation (familial amyloidosis of the Finnish type). J Clin Pathol 2000;53(2):959. Cross Ref link Pubmed link
  • 125  Alvarez‐Lobos M, Hunter B, Cofre C, et al. [Tumor necrosis factor receptor associated periodic syndrome (TRAPS). Report of two cases.] Rev Med Chil 2006;134(12):155861. Pubmed link
  • 126  Kimberley FC, Lobito AA, Siegel RM, Screaton GR. Falling into TRAPS – receptor misfolding in the TNF receptor 1‐associated periodic fever syndrome. Arthritis Res Ther 2007;9(4):217. Cross Ref link Pubmed link
  • 127  Haas N, Kuster W, Zuberbier T, Henz BM. Muckle–Wells syndrome: clinical and histological skin findings compatible with cold air urticaria in a large kindred. Br J Dermatol 2004;151(1):99104. Cross Ref link Pubmed link
  • 128  Muckle TJ, Wellsm. Urticaria, deafness, and amyloidosis: a new heredo‐familial syndrome. Q J Med 1962;31:23548. Pubmed link
  • 129  Jin AG, Por A, Wee LK, Kai CK, Leok GC. Comparative study of phototherapy (UVB) vs. photochemotherapy (PUVA) vs. topical steroids in the treatment of primary cutaneous lichen amyloidosis. Photodermatol Photoimmunol Photomed 2001;17(1):423. Cross Ref link Pubmed link
  • 130  Pandhi R, Kaur I, Kumar B. Lack of effect of dimethylsulphoxide in cutaneous amyloidosis. J Dermatolog Treat 2002;13(1):1114. Cross Ref link Pubmed link
  • 131  Bozikov K, Janezic T. Excision and split thickness skin grafting in the treatment of nodular primary localized cutaneous amyloidosis. Eur J Dermatol 2006;16(3):31516. Pubmed link
  • 132  Lien MH, Railan D, Nelson BR. The efficacy of dermabrasion in the treatment of nodular amyloidosis. J Am Acad Dermatol 1997;36(2 Pt 2):31516. Cross Ref link Pubmed link
  • 133  Alster TS, Manaloto RM. Nodular amyloidosis treated with a pulsed dye laser. Dermatol Surg 1999;25(2):1335. Cross Ref link Pubmed link
  • 134  Truhan AP, Garden JM, Roenigk HH, Jr. Nodular primary localized cutaneous amyloidosis: immunohistochemical evaluation and treatment with the carbon dioxide laser. J Am Acad Dermatol 1986;14(6):105862. Cross Ref link Pubmed link
  • 135  Hernandez‐Nunez A, Dauden E, Moreno de Vega MJ, Fraga J, Aragues M, Garcia‐Diez A. Widespread biphasic amyloidosis: response to acitretin. Clin Exp Dermatol 2001;26(3):2569. Cross Ref link Pubmed link
  • 136  Parsi K, Kossard S. Thermosensitive lichen amyloidosis. Int J Dermatol 2004;43(12):9258. Cross Ref link Pubmed link
  • 137  Wang WJ, Lin CS, Wong CK. Response of systemic amyloidosis to dimethyl sulfoxide. J Am Acad Dermatol 1986;15(2 Pt 2):4025. Cross Ref link Pubmed link
  • 138  Das J, Gogoi RK. Treatment of primary localised cutaneous amyloidosis with cyclophosphamide. Indian J Dermatol Venereol Leprol 2003;69(2):1634. Pubmed link
  • 139  Clos AL, Lasagna‐Reeves CA, Wagner R, Kelly B, Jackson GR, Kayed R. Therapeutic removal of amyloid deposits in cutaneous amyloidosis by localised intra‐lesional injections of anti‐amyloid antibodies. Exp Dermatol 2010;19(10):90411. Cross Ref link Pubmed link
  • 140  Hovey BM, Ward JE, Soo Hoo P, O'Hara CJ, Connors LH, Seldin DC. Preclinical development of siRNA therapeutics for AL amyloidosis. Gene Ther 2011;18(12):11506. Cross Ref link Pubmed link
  • 141  Gattorno M, Federici S, Pelagatti MA, et al. Diagnosis and management of autoinflammatory diseases in childhood. J Clin Immunol 2008;28(Suppl. 1):S7383. Cross Ref link Pubmed link
  • 142  Calligaris L, Marchetti F, Tommasini A, Ventura A. The efficacy of anakinra in an adolescent with colchicine‐resistant familial Mediterranean fever. Eur J Pediatr 2008;167(6):6956. Cross Ref link Pubmed link
  • 143  Lachann HJ, Kone‐Paut I, Kuemmerle‐Deschner JB, et al. Use of canakinumab in the cryopyrin‐associated periodic syndrome. N Engl J Med 2009;360(23):241625. Cross Ref link Pubmed link
  • 144  Mueller SM, Itin P, Haeusermann P. Muckle–Wells syndrome: individualized, reflare‐guided dosing of the orphan drug canakinumab. Skinmed 2013;11(2):803. Pubmed link
  • 145  Savic S, McDermott MF. Inflammation: canakinumab for the cryopyrin‐associated periodic syndromes. Nat Rev Rheumatol 2009;5(10):52930. Cross Ref link Pubmed link
  • 146  Gillespie J, Mathews R, McDermott MF. Rilonacept in the management of cryopyrin‐associated periodic syndromes (CAPS). J Inflamm Res 2010;3:18. Pubmed link
  • 147  Hoffman HM, Throne ML, Amar NJ, et al. Efficacy and safety of rilonacept (interleukin‐1 Trap) in patients with cryopyrin‐associated periodic syndromes: results from two sequential placebo‐controlled studies. Arthritis Rheum 2008;58(8):244352. Cross Ref link Pubmed link
  • 148  Cho SB, Park JS, Kim HO, Chung KY. Scleroderma‐like manifestation in a patient with primary systemic amyloidosis: response to high‐dose intravenous immunoglobulin and plasma exchange. Yonsei Med J 2006;47(5):73740. Cross Ref link Pubmed link
  • 149  Albers SE, Fenske NA, Glass LF, Brozena SJ, Szakacs JE. Atypical beta 2‐microglobulin amyloidosis following short‐term hemodialysis. Am J Dermatopathol 1994;16(2):17984. Cross Ref link Pubmed link
  • 150  Uenotsuchi T, Imafuku S, Nagata M, et al. Cutaneous and lingual papules as a sign of beta 2 microglobulin‐derived amyloidosis in a long‐term hemodialysis patient. Eur J Dermatol 2003;13(4):3935. Pubmed link